glp 1 oral drug Structure Therapeutics GLP-1 Obesity Achieves 'Injectable-Like Efficacy' in Phase 2 Test Daily oral GLP-1 pill delivers
Description
Vilsbll T
We then estimated the treatment adherence effect using marginal structural models incorporating time varying covariates on the composite endpoint
Its associated with modest weight loss
Watch for signs of dehydration: Dark urine, dry mouth, headaches, and dizziness are all signals that you need more fluids
After treatment for 12 months, MDS-UPDRS Part III scores improved slightly by 0.04 points in the lixisenatide group and decreased by 3.04 points in the placebo group
